114 related articles for article (PubMed ID: 11277397)
1. Gene expression analysis of the catalytic subunit of human telomerase (hEST2) in the differential diagnosis of serous effusions.
Nagel H; Schlott T; Schulz GM; Droese M
Diagn Mol Pathol; 2001 Mar; 10(1):60-5. PubMed ID: 11277397
[TBL] [Abstract][Full Text] [Related]
2. In situ telomerase activity in pleural effusions: a promising marker for malignancy.
Dejmek A; Yahata N; Ohyashiki K; Ebihara Y; Kakihana M; Hirano T; Kawate N; Kato H
Diagn Cytopathol; 2001 Jan; 24(1):11-5. PubMed ID: 11135462
[TBL] [Abstract][Full Text] [Related]
3. Pitfalls in TRAP assay in routine detection of malignancy in effusions.
Braunschweig R; Guilleret I; Delacrétaz F; Bosman FT; Mihaescu A; Benhattar J
Diagn Cytopathol; 2001 Oct; 25(4):225-30. PubMed ID: 11599105
[TBL] [Abstract][Full Text] [Related]
4. Static DNA cytometry as a diagnostic aid in effusion cytology: II. DNA aneuploidy for identification of neoplastic cells in equivocal effusions.
Motherby H; Nadjari B; Remmerbach T; Marcy T; Pomjanskaja N; Müller W; Knops K; Häussinger D; Strauer BE; Böcking A
Anal Quant Cytol Histol; 1998 Jun; 20(3):162-8. PubMed ID: 9642442
[TBL] [Abstract][Full Text] [Related]
5. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination.
Braunschweig R; Yan P; Guilleret I; Delacretaz F; Bosman FT; Mihaescu A; Benhattar J
Diagn Cytopathol; 2001 Mar; 24(3):174-80. PubMed ID: 11241900
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced progressive decreasing in the expression of reverse transcriptase gene of hEST2 and telomerase activity.
Zhu H; Xiong S; Cheng W
Chin Med Sci J; 2001 Jun; 16(2):63-6. PubMed ID: 12901491
[TBL] [Abstract][Full Text] [Related]
7. Expressions of human telomerase mRNA component (hTERC) and telomerase reverse transcriptase (hTERT) mRNA in effusion cytology.
Hiroi S; Nakanishi K; Kawai T
Diagn Cytopathol; 2003 Oct; 29(4):212-6. PubMed ID: 14506674
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in effusions: a comparison between telomere repeat amplification protocol in situ and conventional telomere repeat amplification protocol assay.
Hansson M; Zendehrokh N; Ohyashiki J; Ohyashiki K; Westman UB; Roos G; Dejmek A
Arch Pathol Lab Med; 2008 Dec; 132(12):1896-902. PubMed ID: 19061286
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity analyzed with TRAP in situ provides additional information in effusions remaining equivocal after immunocytochemistry and hyaluronan analysis.
Adell E; Dejmek A
Diagn Cytopathol; 2014 Dec; 42(12):1051-7. PubMed ID: 24692425
[TBL] [Abstract][Full Text] [Related]
10. Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids.
Nieh S; Chen SF; Fu E; Jan CI; Lee WH
Acta Cytol; 2005; 49(1):31-7. PubMed ID: 15717752
[TBL] [Abstract][Full Text] [Related]
11. Telomerase enzyme activity as a diagnostic tool to distinguish effusions of malignant and benign origin.
Spangler EA; Rogers KS; Thomas JS; Pustejovsky D; Boyd SL; Shippen DE
J Vet Intern Med; 2000; 14(2):146-50. PubMed ID: 10772485
[TBL] [Abstract][Full Text] [Related]
12. Telomere repeat amplification protocol (TRAP) in situ reveals telomerase activity in three cell types in effusions: malignant cells, proliferative mesothelial cells, and lymphocytes.
Zendehrokh N; Dejmek A
Mod Pathol; 2005 Feb; 18(2):189-96. PubMed ID: 15389260
[TBL] [Abstract][Full Text] [Related]
13. Comparison of NCL-hTERT antibody reactivity and telomere repeat amplification protocol in situ in effusions.
Zendehrokh N; Rehnberg J; Dejmek A
Acta Cytol; 2007; 51(6):886-92. PubMed ID: 18077981
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions.
Passebosc-Faure K; Li G; Lambert C; Cottier M; Gentil-Perret A; Fournel P; Pérol M; Genin C
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6862-7. PubMed ID: 16203775
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity in pleural effusions: diagnostic significance.
Yang CT; Lee MH; Lan RS; Chen JK
J Clin Oncol; 1998 Feb; 16(2):567-73. PubMed ID: 9469342
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.
Wang J; Liu X; Jiang W; Liang L
Chin Med J (Engl); 2000 Nov; 113(11):985-90. PubMed ID: 11776132
[TBL] [Abstract][Full Text] [Related]
17. Cytological diagnosis and telomerase activity of cells in effusions of body cavities.
Toshima S; Arai T; Yasuda Y; Takaya T; Ito Y; Hayakawa K; Shibuya C; Yoshimi N; Shibayama M; Kashiki Y
Oncol Rep; 1999; 6(1):199-203. PubMed ID: 9864428
[TBL] [Abstract][Full Text] [Related]
18. [Relationship among telomerase activity, telomerase RNA and telomerase catalytic subunit gene expression and their significance in non small-cell lung cancer].
Wang J; Liu X; Jiang W
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):289-92. PubMed ID: 11783109
[TBL] [Abstract][Full Text] [Related]
19. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
[TBL] [Abstract][Full Text] [Related]
20. Static DNA cytometry as a diagnostic aid in effusion cytology: I. DNA aneuploidy for identification and differentiation of primary and secondary tumors of the serous membranes.
Motherby H; Marcy T; Hecker M; Ross B; Nadjari B; Auer H; Müller KM; Häussinger D; Strauer BE; Böcking A
Anal Quant Cytol Histol; 1998 Jun; 20(3):153-61. PubMed ID: 9642441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]